ALTRIA GROUP, INC（MO）の決算・業績分析
ALTRIA GROUP, INCの2025年有価証券報告書をAI分析。売上高$23.3B(-3.1%)。営業利益$9.9B。Consumer Staples。
目次
ALTRIA GROUP, INCの2025年度 業績サマリー
ALTRIA GROUP, INC（証券コード: MO）の2025年度決算・業績分析。売上高は$23.3B（前年比-3.1%）。営業利益は$9.9B（前年比-11.9%）。純利益は$6.9B（前年比-38.3%）。有価証券報告書を基に、業績変化の要因・リスク・見通し・セグメント構成を AI が分析しました。
ALTRIA GROUP, INCの2024年度 注目ポイント
※ 直近の2025年度XBRLデータは取込済みですが、AI分析は2024年度の10-Kを対象としています。
- Net Income surged +132.9% YoY to $5.8B (XBRL), driven by cost management and pricing strategies despite -3.5% YoY revenue decline.
- Net Debt/EBITDA ratio stands at 1.7x (XBRL), reflecting high leverage despite $8.1B Free Cash Flow (FCF) generated in FY2024.
- Payout Ratio of 114.5% (XBRL) indicates aggressive shareholder returns, with $6.6B in dividends and $1.8B in buybacks.
- Equity Ratio of -9.2% (XBRL) and Total Equity of -$3.5B (10-K) highlight significant debt-driven capital structure.
ALTRIA GROUP, INCの売上高変化の要因
- •FY2024 Revenue declined -3.5% YoY to $25.1B (XBRL), reflecting ongoing volume declines in traditional cigarette sales. However, growth in e-vapor and nicotine pouch categories may offset some of these declines. Segment-specific revenue data is not disclosed in the XBRL or 10-K (N/A). Historical time series shows revenue peaked at $26.2B in FY2022 before declining to $25.1B in FY2024 (Historical Time Series). Growth drivers include product innovation (e.g., NJOY acquisition) and expansion into alternative nicotine delivery systems.
ALTRIA GROUP, INCの営業利益変化の要因
- •Profitability improved significantly in FY2024: Operating Income rose +3.1% YoY to $11.9B (XBRL), while Net Income surged +132.9% YoY to $5.8B (XBRL). Gross Margin of 56.8% (XBRL) and Operating Margin of 47.5% (XBRL) indicate strong cost control. EBITDA of $12.1B (48.4% of revenue) reflects efficient operations. Despite revenue declines, margin expansion and cost management drove profitability gains.
ALTRIA GROUP, INCの事業リスクと対応
Consumer behavior shifts (e.g., down-trading to discount brands, moving to e-vapor products) could reduce premium brand sales and margins (10-K).
Intense competition and antitrust risks due to market leadership positions threaten profitability (10-K).
Inflation and economic instability may force consumers to cut spending on premium products, worsening volume declines (10-K).
Failure to innovate or expand product portfolios risks losing market share to competitors (10-K).
Inability to offset volume declines through price increases could harm financial performance (10-K).
ALTRIA GROUP, INCの事業内容
Altria Group, Inc. (MO) operates as a leading manufacturer and seller of tobacco products for U.S. consumers aged 21+ (10-K). Its core business model generates revenue through the sale of cigarettes, cigars, smokeless tobacco, e-vapor products (NJOY), and oral nicotine pouches, with a strategic focus on transitioning adult smokers to less harmful alternatives. Key segments include smokeable products (cigarettes, cigars) and oral tobacco products (moist smokeless tobacco, nicotine pouches), supported by partnerships like the heated tobacco joint venture with Japan Tobacco. Competitive advantages include strong brand equity (e.g., Marlboro), strategic acquisitions (NJOY), and diversified product portfolios. No significant customer concentration is reported (10-K).
ALTRIA GROUP, INCのAI業績分析レポート（2024年度）
Altria Group, Inc. (MO) FY2024 Annual Report Analysis
Highlights
Business Overview
Altria Group, Inc. operates as a leading manufacturer and seller of tobacco products for U.S. consumers aged 21+ (10-K). Its core business model generates revenue through the sale of cigarettes, cigars, smokeless tobacco, e-vapor products (NJOY), and oral nicotine pouches, with a strategic focus on transitioning adult smokers to less harmful alternatives. Key segments include smokeable products (cigarettes, cigars) and oral tobacco products (moist smokeless tobacco, nicotine pouches), supported by partnerships like the heated tobacco joint venture with Japan Tobacco. Competitive advantages include strong brand equity (e.g., Marlboro), strategic acquisitions (NJOY), and diversified product portfolios. No significant customer concentration is reported (10-K).
Revenue Analysis
FY2024 Revenue declined -3.5% YoY to $25.1B (XBRL), reflecting ongoing volume declines in traditional cigarette sales. However, growth in e-vapor and nicotine pouch categories may offset some of these declines. Segment-specific revenue data is not disclosed in the XBRL or 10-K (N/A). Historical time series shows revenue peaked at $26.2B in FY2022 before declining to $25.1B in FY2024:
| Metric | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | 25.4B | 25.1B | 26.2B | 26.0B | 25.1B | 24.5B |
| Operating Income | 9.1B | 10.3B | 10.9B | 11.6B | 11.9B | 11.5B |
| Net Income | 7.0B | -1.3B | 4.5B | 2.5B | 5.8B | 8.1B |
| Total Assets | 49.3B | 47.4B | 39.5B | 37.0B | 38.6B | 35.2B |
| Total Equity | 6.2B | 2.8B | -1.6B | -4.0B | -3.5B | -2.2B |
| Operating Cash Flow | 8.4B | 7.8B | 8.4B | 8.4B | 8.3B | 9.3B |
Growth drivers include product innovation (e.g., NJOY acquisition) and expansion into alternative nicotine delivery systems.
Profitability Analysis
Profitability improved significantly in FY2024: Operating Income rose +3.1% YoY to $11.9B (XBRL), while Net Income surged +132.9% YoY to $5.8B (XBRL). Gross Margin of 56.8% (XBRL) and Operating Margin of 47.5% (XBRL) indicate strong cost control. EBITDA of $12.1B (48.4% of revenue) reflects efficient operations. Despite revenue declines, margin expansion and cost management drove profitability gains.
Balance Sheet Analysis
Total Equity declined to -$3.5B (10-K) in FY2024, with a negative Equity Ratio of -9.2% (XBRL) and a Debt/Equity Ratio of -11.88x (XBRL), signaling extreme leverage. Long-Term Debt of $25.1B (XBRL) and Net Debt of $21.1B (1.7x EBITDA) highlight significant financial risk. Current Ratio of 0.49x (XBRL) indicates liquidity challenges, though Cash reserves of $4.0B (XBRL) provide some buffer.
Cash Flow Analysis
Operating Cash Flow (OCF) remained stable at $8.3B (XBRL), with Free Cash Flow (FCF) of $8.1B (XBRL) after $205M in CapEx. Investing Cash Flow of $782M (XBRL) includes proceeds from the sale of IQOS System commercialization rights and the NJOY acquisition. Financing Cash Flow of -$9.5B (XBRL) reflects $6.6B in dividends and $1.8B in share repurchases.
Working Capital Analysis
N/A
Risks
Consumer Staplesの企業一覧
ALTRIA GROUP, INCと同じ「Consumer Staples」セクターの企業